News

Chemists and biologists have developed a tiny device that can locate tumor cells and force them to reveal themselves to patrolling immune cells.

A meta-analysis study has indicated that individuals in the highest percentile for height had a higher risk of developing colorectal cancer than those in the lowest percentile.

Bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days with a treatment that could be ready for human clinical trials later this year.

According to research, it may be possible to identify the presence of an aggressive brain tumor in children by studying their cerebrospinal fluid.

Researchers have discovered a non-genetic adaptation that could be driving resistance to targeted therapy in T cell leukemia, a type of blood cell cancer.

The mechanism by which multiple myeloma develops drug resistance is characterized by an increase in CDK6 production, providing researchers with a new treatment target.

Researchers have developed a more efficient way to develop breast cancer models using tumors donated by breast cancer patients. They have also proposed a process to test potential drugs to help prioritize therapeutic choices based on specific tumor characteristics.

According to research, statins, which are prescribed as cholesterol-lowering drugs, inhibit the expression of a metastasis-associated gene in tumor cells.

Researchers have developed a new precision medicine technology that can carry out comprehensive mapping of the whole cell surface tumor antigen landscape in patients. The technology could help to create new successful immunotherapies to treat cancer.

A clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.